Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.
about
Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.Evaluation of anticoagulants for serologic assays of cholera vaccinationThe lung mast cell: its physiology and potential relevance to defense of the lung.Neuronal death in Alzheimer's disease and therapeutic opportunities.Methylprednisolone inhibits the alternative and amplification pathways of complement.Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3bSteroids inhibit activation of the alternative-amplification pathway of complement.Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase.Anticomplement therapy.Detection of Pseudomonas aeruginosa antigenemia in granulocytopenic rabbits by radiommunoassay.The use of heparin for preventing miscarriage.Mast cells in allergic diseases and mastocytosis.Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After AdministrationThe human lung mast cell.Mast cells: accessory cells which potentiate fibrosis.Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate).Effect of heparin on pulmonary fibroblasts and vascular cells.Oxidative degradation of rat mast-cell heparin proteoglycan.Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.Interaction of poly(styrene sulfonic acid) with the alternative pathway of the serum complement system.Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways.Dextran sulfate as a material for the preparation of a membrane for immunoisolation.Effect of salbutamol, fenoterol, and sodium cromoglycate on the release of heparin from sensitized human lung fragments challenged with Dermatophagoides pteronyssinus allergen.
P2860
Q33596128-733EF412-D8E1-4705-87BF-83E726D3FBB5Q33743433-BD6F36BC-DADA-4D5F-8AE7-A0D6D94AB4D3Q35035232-2CBB2AE3-3E2C-453A-9D9F-3DA5CD5C6EC5Q35889067-5615AD38-77CA-4344-81A8-DED58C36D7FDQ36335057-6C3779F4-0BE5-47AA-8CD9-3DEED056B9EDQ36343010-FB0DF516-EE9C-48E8-A07B-1D9BDBF5FAD9Q36348295-9668FEEB-B9E0-47AF-B80A-F301E76F4B90Q37026070-3F3BD249-D651-4EB0-ACDD-FDC37FFD4A55Q37307880-D755ED29-8385-4B0B-9B9E-09E330BB2A86Q37326454-C87151D7-06AF-4188-8BDB-83FE49A8E9FCQ37995711-9A7B7CF2-A754-49A9-AD0F-49DCE81AB318Q39399589-64A07C56-7FCF-4D9E-9897-BBE9F533B105Q39633236-888785AA-AF59-492C-9044-C7F97C91DFC3Q40212548-1CD167A2-9854-4509-AE71-A61B652DACD3Q40403511-25D4EBC6-5631-4248-895B-2E39DB8C5096Q40862339-3882C6F1-FFE8-4103-B56B-0332817CB92FQ41147119-79A9B55C-E5A5-4F33-AFCB-121BA888DE34Q42859290-C999E385-4C82-4CDC-B474-5DAB54F0F40BQ45111033-9F6407D9-D4C8-404D-AC7C-EF6DC771FA41Q46454257-B40B3953-E9BE-4E5E-AE78-291CB13962EEQ48371887-428D5481-28CE-4B8D-B5C3-438F03A16341Q51788128-3E88B95C-3DA4-4D07-A4FC-A1BBBB45E2FEQ53748838-A2C59494-CD49-47B4-A892-3C853AD39833
P2860
Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Modulation of the formation of ...... native and commercial heparin.
@ast
Modulation of the formation of ...... native and commercial heparin.
@en
type
label
Modulation of the formation of ...... native and commercial heparin.
@ast
Modulation of the formation of ...... native and commercial heparin.
@en
prefLabel
Modulation of the formation of ...... native and commercial heparin.
@ast
Modulation of the formation of ...... native and commercial heparin.
@en
P2093
P2860
P356
P1476
Modulation of the formation of ...... native and commercial heparin.
@en
P2093
P2860
P304
P356
10.1084/JEM.147.2.409
P407
P577
1978-02-01T00:00:00Z